Abstract
The pan-JAK inhibitor tofacitinib improves the delivery of therapeutic antibodies in cancer.
- Copyright © 2019, American Association for the Advancement of Science
The pan-JAK inhibitor tofacitinib improves the delivery of therapeutic antibodies in cancer.